Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Astera Labs Stock Up 0.6%
Astera Labs stock traded up $0.82 during trading hours on Friday, hitting $133.44. The stock had a trading volume of 1,170,251 shares, compared to its average volume of 5,611,533. The stock’s 50-day moving average price is $160.78 and its 200-day moving average price is $174.12. The stock has a market capitalization of $22.54 billion, a P/E ratio of 109.32, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Hedge Funds Weigh In On Astera Labs
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on ALAB shares. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Northland Securities raised their target price on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. TD Cowen reiterated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, January 21st. Finally, Needham & Company LLC upped their price objective on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $192.89.
Check Out Our Latest Stock Report on Astera Labs
More Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Analyst note: Zacks highlights rising AI connectivity demand and Astera’s expansion of its NVLink and Scorpio product lines, framing a multiyear market opportunity that management is targeting (potential upside to revenue growth). ALAB Rides on Strong Connectivity Demand
- Positive Sentiment: Fundamentals & liquidity: A Seeking Alpha piece notes revenue more than doubled YoY, very strong free cash flow margins (above 30%), and a cash position of roughly $1.19B with zero debt — giving Astera financial flexibility to invest or weather headwinds. The Great Astera Labs Reset
- Neutral Sentiment: Short-interest data is effectively immaterial/odd (reported as zero shares and a 0.0 days ratio), so there’s no clear short-pressure signal to explain intraday moves. This looks like a non-factor for current trading dynamics. Short Interest Report
- Negative Sentiment: CEO sale: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (≈$11.76M), trimming his holding by ~6.14% — a large, pre-scheduled or open-market sale that can be viewed negatively by the market when combined with other insider activity. CEO Form 4
- Negative Sentiment: COO sale: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (≈$11.76M), reducing his position by ~5.84% — another large insider disposition on the same date that amplifies investor concern. COO Form 4
- Negative Sentiment: CFO sale: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (≈$1.49M), cutting his stake by ~5.88% — another senior officer sale the same day. CFO Form 4
- Negative Sentiment: General Counsel sale: GC Philip Mazzara sold 4,849 shares at ~$123.80 (≈$600k), a smaller but concurrent insider reduction. Multiple senior officers selling on the same day increases perceived signal of near‑term liquidity taking or diversification by insiders. GC Form 4
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- 3 Signs You May Want to Switch Financial Advisors
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
